Personalized treatment plans with multivariate outcomes
Chathura Siriwardhana1, Karunarathna B Kulasekera2
1Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Biometrical Journal. Biometrische Zeitschrift
|July 7, 2020
Summary
This study introduces a new method for selecting the best treatment for individuals with complex health conditions. It uses a unique distance measure to rank treatments based on performance, aiding optimal treatment selection.
Area of Science:
- Biostatistics
- Medical Informatics
- Clinical Trial Design
Background:
- Individualized treatment selection is challenging with multivariate responses.
- Existing methods may not accommodate a wide range of models or numerous treatments.
Purpose of the Study:
- To propose a novel, flexible method for individualized treatment selection with multivariate outcomes.
- To establish an ordering of treatments based on performance measures using a Mahalanobis-type distance.
Main Methods:
- Utilizes single index models to approximate conditional mean responses based on patient covariates.
- Employs smoothed estimates of conditional means to construct a distance measure for treatment comparison.
- Applies the distance measure to estimate the optimal treatment for individuals.
Main Results:
- The proposed method demonstrates effective performance in finite sample simulations.
- The empirical study validates the method's utility in ranking treatments for individualized selection.
- The approach is applicable to various statistical models and any number of treatments.
Conclusions:
- The novel method provides a robust framework for optimal treatment selection in multivariate settings.
- The Mahalanobis-type distance measure effectively guides treatment choice based on predicted patient response.
- The method's applicability is confirmed through simulation and real-world HIV clinical trial data analysis.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Cancer Survival Analysis
568
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
568
Kaplan-Meier Approach
460
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
460
Dosage Regimen: Individualization
103
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
103
Dosage Regimen Designs: Nomograms and Tabulations
97
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
97
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K


